NCT05616013: Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
- State
- Completed
- Phase
- Phase 2
- People
- 507 taking part
- Started
- 16 Nov 2022
- Primary completion
- 16 May 2024
- Arms
- 10/30 mg/kg Bimagrumab, 30 mg/kg Bimagrumab
- Results
- Posted on the registry
- 14 Nov 2022: Trial registered
- 16 Nov 2022: Trial started
- 14 Jun 2025: Trial completed
- 18 Jul 2025: Trial results posted